Factors associated with the decision to undergo risk-reducing salpingo-oophorectomy among women at high risk for hereditary breast and ovarian cancer: a systematic review

키워드

참고문헌 (40)

1. Dan L. Longo, "The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer", New England Journal of Medicine, 374(5), pp.454~468 (2016), Massachusetts Medical Society[DOI]
2. Nancie Petrucelli, "Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2", Genetics in Medicine, 12(5), pp.245~259 (2010), Springer Science and Business Media LLC[DOI]
3. Eunyoung Kang, "The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study", Breast Cancer Research and Treatment, 151(1), pp.157~168 (2015), Springer Science and Business Media LLC[DOI]
4. Rebbeck TR, "Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers", J Natl Cancer Inst, 101(2), pp.80~87 (2009)[DOI]
5. Tasleem J. Padamsee, "Decision making for breast cancer prevention among women at elevated risk", Breast Cancer Research, 19(1), pp.34~ (2017), Springer Science and Business Media LLC[DOI]
6. Rachel Meadows, "Distinctive psychological and social experiences of women choosing prophylactic oophorectomy for cancer prevention", Health Care for Women International, 39(5), pp.595~616 (2018), Informa UK Limited[DOI]
7. A. Fuchsia Howard, "Women’s Decision Making about Risk-Reducing Strategies in the Context of Hereditary Breast and Ovarian Cancer: A Systematic Review", Journal of Genetic Counseling, 18(6), pp.578~597 (2009), Wiley[DOI]
8. Martha Hickey, "What information do healthcare professionals need to inform premenopausal women about risk-reducing salpingo-oophorectomy?", Menopause, 27(1), pp.20~25 (2020), Ovid Technologies (Wolters Kluwer Health)[DOI]
9. Carol Cherry, "Understanding the Needs of Women Considering Risk-Reducing Salpingo-oophorectomy", Cancer Nursing, 36(3), pp.E33~E38 (2013), Ovid Technologies (Wolters Kluwer Health)[DOI]
10. Shoshana M. Rosenberg, "“I don't want to take chances.”: A qualitative exploration of surgical decision making in young breast cancer survivors", Psycho-Oncology, 27(6), pp.1524~1529 (2018), Wiley[DOI]
11. Angela R Bradbury, "Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers", Genetics in Medicine, 10(3), pp.161~166 (2008), Springer Science and Business Media LLC[DOI]
12. Dongwon Kim, "Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation", Familial Cancer, 12(4), pp.621~628 (2013), Springer Science and Business Media LLC[DOI]
13. Krishna Singh, "Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers", American Journal of Obstetrics and Gynecology, 208(4), pp.329.e1~329.e6 (2013), Elsevier BV[DOI]
14. Se Ik Kim, "Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea", Journal of Cancer Research and Clinical Oncology, 142(1), pp.333~340 (2016), Springer Science and Business Media LLC[DOI]
15. David Moher, "Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement", PLoS Medicine, 6(7), pp.e1000097~ (2009), Public Library of Science (PLoS)[DOI]
16. Soo Young Kim, "Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity", Journal of Clinical Epidemiology, 66(4), pp.408~414 (2013), Elsevier BV[DOI]
17. Claire C. Conley, "Factors associated with intentions for breast cancer risk management: Does risk group matter?", Psycho-Oncology, 28(5), pp.1119~1126 (2019), Wiley[DOI]
18. Siranoush Manoukian, "Risk-reducing surgery in BRCA1", BRCA2 mutation carriers: are there factors associated with the choice?, 2019, pp.28(9), 1871~1878[DOI]
19. M. Robyn Andersen, "False-positive screening events and worry influence decisions about surgery among high-risk women", Health Psychology, 38(1), pp.43~52 (2019), American Psychological Association (APA)[DOI]
20. Ladd MK, "Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer", Transl Behav Med, 10(2), pp.337~346 (2020)[DOI]
21. Angie Tong, "Intentions for risk-reducing surgery among high-risk women referred for BRCA1", BRCA2 genetic counseling, 2015, pp.24(1), 33~39[DOI]
22. Jessica E. van der Aa, "The effect of personal medical history and family history of cancer on the uptake of risk-reducing salpingo-oophorectomy", Familial Cancer, 14(4), pp.539~544 (2015), Springer Science and Business Media LLC[DOI]
23. R Manchanda, "Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis", BJOG: An International Journal of Obstetrics & Gynaecology, 119(5), pp.527~536 (2012), Wiley[DOI]
24. L Sidon, "Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women", British Journal of Cancer, 106(4), pp.775~779 (2012), Springer Science and Business Media LLC[DOI]
25. Claire Julian-Reynier, "Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1", 2 mutations, 2011, pp.19(5), 500~506[DOI]
26. A-B Skytte, "Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing", Clinical Genetics, 77(4), pp.342~349 (2010), Wiley[DOI]
27. Mary S. Beattie, "Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers", Genetic Testing and Molecular Biomarkers, 13(1), pp.51~56 (2009), Mary Ann Liebert Inc[DOI]
28. Tara M. Friebel, "Bilateral Prophylactic Oophorectomy and Bilateral Prophylactic Mastectomy in a Prospective Cohort of Unaffected BRCA1 and BRCA2 Mutation Carriers", Clinical Breast Cancer, 7(11), pp.875~882 (2007), Elsevier BV[DOI]
29. Joanna B. Madalinska, "Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1", 2 mutation carriers, 2007, pp.25(3), 301~307[DOI]
30. Vardit Kram, "Acceptance of Preventive Surgeries by Israeli Women Who had Undergone BRCA Testing", Familial Cancer, 5(4), pp.327~335 (2006), Springer Science and Business Media LLC[DOI]
31. Erna Claes, "Surveillance Behavior and Prophylactic Surgery After Predictive Testing for Hereditary Breast", Ovarian Cancer, 2005, pp.31(3), 93~106[DOI]
32. Marc D. Schwartz, "Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1", BRCA2 mutation testing, 2003, pp.21(21), 4034~4041[DOI]
33. Carolyn Y Fang, "Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer", Preventive Medicine, 37(5), pp.424~431 (2003), Elsevier BV[DOI]
34. Karen E. Hurley, "Anxiety", Uncertainty Reduction as a Motivation for Interest in Prophylactic Oophorectomy in Women with a Family History of Ovarian Cancer, 2001, pp.10(2), 189~199[DOI]
35. Alison Fry, "Deciding about Prophylactic Oophorectomy: What Is Important to Women at Increased Risk of Ovarian Cancer?", Preventive Medicine, 33(6), pp.578~585 (2001), Elsevier BV[DOI]
36. Bettina Meiser, "Attitudes toward Prophylactic Oophorectomy and Screening Utilization in Women at Increased Risk of Developing Hereditary Breast", Ovarian Cancer, 1999, pp.75(1), 122~129[DOI]
37. Rachael Glassey, "Decision making, psychological wellbeing and psychosocial outcomes for high risk women who choose to undergo bilateral prophylactic mastectomy – A review of the literature", The Breast, 28, pp.130~135 (2016), Elsevier BV[DOI]
38. Brittany Ager, "Contralateral prophylactic mastectomy (CPM): A systematic review of patient reported factors and psychological predictors influencing choice and satisfaction", The Breast, 28, pp.107~120 (2016), Elsevier BV[DOI]
39. Shirley Sun, "Factors shaping at‐risk individuals’ decisions to undergo genetic testing for cancer in Asia", Health & Social Care in the Community, 28(5), pp.1569~1577 (2020), Wiley[DOI]
40. Iman Haroun, "Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer", The Breast, 20(3), pp.254~258 (2011), Elsevier BV[DOI]

관련 논문AI추천